Vycor Medical, Inc. is a cutting-edge company focusing on innovative neurosurgical solutions, founded in 2005 with the motto, "There must be a better way." The company aims to revolutionize the field of brain and spine surgery by providing a less invasive approach to critical procedures, leading to reduced collateral trauma and faster postoperative recovery. Their flagship product, ViewSite Brain Access System (VBAS), is designed to improve surgical retraction and access to brain sites, minimizing damage to surrounding tissue. With a commitment to enhancing patient outcomes, Vycor Medical is at the forefront of making neurosurgery procedures safer and more effective. The company, headquartered in the United States, received a $1.28M post-IPO equity investment on January 8, 2014. VYCOR MEDICAL® is a registered trademark of Vycor Medical, Inc., reflecting the company's dedication to pioneering advancements in the biotechnology, hardware, and health care industries.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity | $1.28M | - | 08 Jan 2014 | |
Post-IPO Equity | $3.00M | - | 02 Dec 2011 |
No recent news or press coverage available for Vycor Medical, Inc..